Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL423846 | 0.87 | LMNA (0.41) | LMNA | |
| SCHEMBL1932322 | 0.87 | — | — | |
| SCHEMBL6990184 | 0.85 | LMNA (0.46) | LMNA | |
| SCHEMBL380860 | 0.83 | LMNA (0.30) | LMNA | |
| SCHEMBL942111 | 0.83 | — | — | |
| SCHEMBL2379126 | 0.83 | LMNA (0.32) | LMNA | |
| SCHEMBL2999056 | 0.83 | TSHR (0.38) | LMNA | |
| SCHEMBL1045278 | 0.81 | — | — | |
| SCHEMBL8076785 | 0.81 | — | — | |
| SCHEMBL8175475 | 0.81 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6277537-B1 | PHENOLIC COMPOUND | EASTMAN KODAK COMPANY | 2001-08-21 | — | — | US | claimed |
| US-5512410-A | Heat image separation with phenolic thermal solvents and dye releasing couplers | EASTMAN KODAK COMPANY (US) | 1996-04-30 | — | — | US | claimed |
| US-11860535-B2 | Imprint lithography stamp method of making and using the same | KONINKLIJKE PHILIPS N.V. (NL) | 2024-01-02 | — | — | US | disclosed |
| US-11163230-B2 | Imprint lithography stamp method of making and using the same | KONINKLIJKE PHILIPS N.V. (NL) | 2021-11-02 | — | — | US | disclosed |
| US-20210079167-A1 | IMPRINT LITHOGRAPHY STAMP METHOD OF MAKING AND USING THE SAME | KONINKLIJKE PHILIPS N.V. (NL) | 2021-03-18 | — | — | US | disclosed |
| US-20200223859-A1 | REDUCTION OF ALPHA, BETA-UNSATURATED KETONE LEVELS IN MORPHINAN DERIVATIVE COMPOSITIONS | RHODES TECHNOLOGIES (US) | 2020-07-16 | — | — | US | disclosed |
| EP-3440509-B1 | IMPRINT LITHOGRAPHY STAMP, METHOD OF MAKING AND USING THE SAME | KONINKLIJKE PHILIPS NV (NL) | 2020-06-17 | — | — | EP | disclosed |
| EP-3440509-A1 | IMPRINT LITHOGRAPHY STAMP METHOD OF MAKING AND USING THE SAME | Koninklijke Philips N.V. (NL) | 2019-02-13 | — | — | EP | disclosed |
| US-20170342084-A1 | REDUCTION OF ALPHA, BETA-UNSATURATED KETONE LEVELS IN MORPHINAN DERIVATIVE COMPOSITIONS | RHODES TECHNOLOGIES | 2017-11-30 | — | — | US | disclosed |
| WO-2017174755-A1 | IMPRINT LITHOGRAPHY STAMP METHOD OF MAKING AND USING THE SAME | KONINKLIJKE PHILIPS N.V. (NL) | 2017-10-12 | — | — | WO | disclosed |
| US-6277537-B1 | PHENOLIC COMPOUND | EASTMAN KODAK COMPANY | 2001-08-21 | — | — | US | disclosed |
| US-6156690-A | Solid catalyst component and catalyst for polymerization of olefins | TOHO TITANIUM CO., LTD. (JP) | 2000-12-05 | — | — | US | disclosed |
| US-5521039-A | NOVEL CHARAGE GENERATING MATERIAL IS DISAZO COMPOUND CONTAINING ALKYNE GROUP | FUJI PHOTO FILM CO., LTD. (JP) | 1996-05-28 | — | — | US | disclosed |
| US-5512410-A | Heat image separation with phenolic thermal solvents and dye releasing couplers | EASTMAN KODAK COMPANY (US) | 1996-04-30 | — | — | US | disclosed |
| US-5356750-A | Dye releasing couplers for heat image separation systems | EASTMAN KODAK COMPANY (US) | 1994-10-18 | — | — | US | disclosed |
| US-4459300-A | ANTIEMETICS, GASTROINTESTINAL DISORDERS, CENTRAL NERVOUS SYSTEM, PSYCHOLOGICAL DISORDERS | BEECHAM GROUP P.L.C. (GB) | 1984-07-10 | — | — | US | disclosed |
| EP-0069482-A1 | Azabicycloalkyl benzamides, process for their preparation and pharmaceutical compositions containing them | BEECHAM GROUP PLC (GB) | 1983-01-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170342084-A1 | REDUCTION OF ALPHA, BETA-UNSATURATED KETONE LEVELS IN MORPHINAN DERIVATIVE COMPOSITIONS | FASN, HSD17B7, DEGS1 | LMNA 20/4885CA1 2094/4885 |
| US-20200223859-A1 | REDUCTION OF ALPHA, BETA-UNSATURATED KETONE LEVELS IN MORPHINAN DERIVATIVE COMPOSITIONS | FASN, HSD17B7, DEGS1 | LMNA 20/4885CA1 2094/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.